熱門資訊> 正文
Dogwood Therapeutics重新与纳斯达克合规
2025-04-03 21:08
- Dogwood Therapeutics (NASDAQ:DWTX) said it has regained compliance with the minimum stockholders’ equity requirement.
- “The company has a strong cash position of $17.5 million as of the end of Q1, with no debt, better positioning the company to advance its continued mission to build shareholder value," said CEO Greg Duncan.
More on Dogwood Therapeutics
- Dogwood Therapeutics announces pricing of $4.8 million offering
- Dogwood Therapeutics announces conversion of existing $19.5M in debt to equity
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
